Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD5 | P21918 | 1/20 | 0.31 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9117904 | 0.80 | CYP3A4 (0.36) | CYP3A4 | |
| SCHEMBL9562060 | 0.77 | ALDH1A1 (0.41) | CYP3A4 | |
| SCHEMBL9392813 | 0.76 | P2RY6 (0.41) | DRD5P2RY6CYP3A4 | |
| SCHEMBL2298411 | 0.74 | TLR3 (0.34) | CYP3A4 | |
| SCHEMBL10335845 | 0.70 | TSHR (0.43) | CYP3A4 | |
| SCHEMBL669225 | 0.70 | CYP3A4 (0.59) | CYP3A4 | |
| SCHEMBL8133593 | 0.70 | SLC5A2 (0.48) | — | |
| SCHEMBL1211 | 0.67 | IDO1 (0.61) | — | |
| SCHEMBL67998 | 0.67 | P2RY6 (0.33) | DRD5P2RY6 | |
| SCHEMBL96363 | 0.66 | TSHR (0.57) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230092024-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | CENTRILLION TECHNOLOGIES, INC. | 2023-03-23 | — | — | US | claimed |
| CN-102782580-B | Pattern forming method | NIPPON KOGAKU KK | 2015-04-22 | — | — | CN | claimed |
| EP-1427743-A4 | PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES | EPOCH BIOSCIENCES INC (US) | 2007-04-04 | — | — | EP | claimed |
| EP-1427743-A2 | PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES | Epoch Biosciences, Inc. (US) | 2004-06-16 | — | — | EP | claimed |
| WO-2003022859-A2 | PROCESS FOR THE SYNTHESIS OF PYRAZOLOPYRIMIDINES | EPOCH BIOSCIENCES, INC. (US) | 2003-03-20 | — | — | WO | claimed |
| US-5482867-A | Spatially-addressable immobilization of anti-ligands on surfaces | AFFYMAX TECHNOLOGIES N.V. (NL) | 1996-01-09 | — | — | US | claimed |
| US-20230092024-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | CENTRILLION TECHNOLOGIES, INC. | 2023-03-23 | — | — | US | disclosed |
| WO-2021117680-A1 | BIOLOGICAL SUBSTANCE IMMOBILIZATION MATERIAL | 国立大学法人 東京大学 | 2021-06-17 | — | — | WO | disclosed |
| EP-3802847-A1 | INCREASING EFFICIENCY OF PHOTOCHEMICAL REACTIONS ON SUBSTRATES | Centrillion Technologies, Inc. (US) | 2021-04-14 | — | — | EP | disclosed |
| CN-107108796-B | Polymer compound, surface treatment agent, laminate using surface treatment agent, transistor, and method for producing laminate | 株式会社尼康 | 2019-10-01 | — | — | CN | disclosed |
| CN-107108796-A | Polymer compound, surface treatment agent, laminate using surface treatment agent, transistor, and method for producing laminate | 株式会社尼康 | 2017-08-29 | — | — | CN | disclosed |
| EP-2267165-B1 | Nucleic acid sequence analysis | GEN PROBE INC (US) | 2016-11-30 | — | — | EP | disclosed |
| EP-2267164-B1 | Nucleic acid sequence analysis | GEN PROBE INC (US) | 2016-09-14 | — | — | EP | disclosed |
| EP-1017848-A2 | NUCLEIC ACID SEQUENCE ANALYSIS | Medical Biosystems Ltd. (GB) | 2000-07-12 | — | — | EP | disclosed |
| WO-1999054509-A1 | METHODS FOR REDUCING NON-SPECIFIC BINDING TO A NUCLEIC ACID PROBE ARRAY | AFFYMETRIX, INC. (US) | 1999-10-28 | — | — | WO | disclosed |
| EP-0950112-A1 | PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS | Affymetrix, Inc. (a California Corporation) (US) | 1999-10-20 | — | — | EP | disclosed |
| US-5959098-A | ACTIVATING AND COUPLING MONOMERS IN DIFFERENT SELECTED ZONES OF SUBSTRATE FORMING DIFFERENT SEQUENCES IN DIFFERENT AREAS; ACTIVATING BY DIRECTING RADIATION AT SURFACE OF SUBSTRATE WITH FUNCTIONAL GROUPS PROTECTED BY PHOTOLABILE GROUPS | AFFYMETRIX, INC. (US) | 1999-09-28 | — | — | US | disclosed |
| WO-1999005315-A2 | NUCLEIC ACID SEQUENCE ANALYSIS | MEDICAL BIOSYSTEMS LTD. (GB) | 1999-02-04 | — | — | WO | disclosed |
| WO-1997039151-A1 | PHOTOLABILE POLYMER ARRAY SYNTHESIS METHODS | AFFYMETRIX, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1994010128-A1 | NOVEL PHOTOREACTIVE PROTECTING GROUPS | AFFYMAX TECHNOLOGIES N.V. (AN) | 1994-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230092024-A1 | Increasing Efficiency Of Photochemical Reactions On Substrates | TYR, PCNA, DNMT1 | DRD5 3833/4885P2RY6 3752/4885CYP3A4 472/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.